1. Dolezal JM, Wang H, Kulkarni S, Jackson L, Lu J, Ranganathan S, Goetzman ES, Bharathi S, Beezhold K, Byersdorfer CA, Prochownik EV. Sequential Adaptive Changes in a c-Myc-Driven Model of Hepatocellular Carcinoma. J Biol Chem. 2017. Epub ahead of print. PMID: 28432125
2. Tkachev V, Goodell S, Opipari AW, Franchi L, Hao, LY, Glick GD, Ferrara JLM, and Byersdorfer CA, Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015. 194(12):5789. PMID: 25972478
3. Gleimer, M., Li, Y., Chang, L., Paczesny, S., Hanauer, D.A., Frame, D.G., Byersdorfer CA, Reddy, P.R., Braun, T.M., and S.W. Choi.  Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. BMT. 2015. 50(3):402. PMID: 25531283
4. G.D. Glick, R. Rossignol, C. A. Lyssiotis, D. Wahl, C. Lesch, B. Sanchez, X. Liu, L.Y. Hao, C. Taylor, A. Hurd, J. LM. Ferrara, V. Tkachev, Byersdorfer CA, L. Boros and A. W. Opipari.  Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. J. Pharm. Exp. Ther. 2014. 351(2):298. PMID: 25125579
5. Byersdorfer CA, Tkachev V, Opipari AW, Goodell S, Swanson J, Sandquist S, Glick GD, and JLM Ferrara. Effector T cells require fatty acid metabolism during murine graft-versus-host disease. Blood. 2013. 122(18):3230-3237. PMID: 24046012